Skip to main content
. 2022 Jul 28;11(15):2257. doi: 10.3390/foods11152257

Table 5.

SALDI mass spectrum of Weissella cibaria lipid extract made on an AgNLET plate with electroplated silver nanoparticles (S/N ≥ 5, Δ max. ± 10 ppm).

graphic file with name foods-11-02257-i002.jpg
Compound * Adduct Formula m/z Exp. m/z Calc. Δ (ppm)
1. [FA hydroxy(15:0)] 2-hydroxy-pentadecanoic acid [C15H30O3 + 107Ag]+ 365.12 365.12 0.0
2. N-palmitoyl proline [C21H39NO3 + Na]+ 376.28 376.28 0.0
3. Galactan [C14H26O11 + Na]+ 393.14 393.14 0.0
4. [PC (6:0)] 1-hexanoyl-sn-glycero3-phosphocholine [C14H30NO7P + K]+ 394.14 394.14 0.0
5. 2-hydroxy-9Z,12Z,15Z-octadecatrienoic acid [C18H30O3 + 109Ag]+ 403.12 403.12 0.0
6. Met-Tyr [C14H20N2O4S + 107Ag]+ 419.02 419.02 0.0
7. [PC (3:0)] 1-(2E-propionyl)sn-glycero-3- phosphocholine [C11H22NO7P + 109Ag]+ 420.02 420.02 0.0
8. S-(2-Chloroacetyl)glutathione [C12H18N3O7ClS + K]+ 422.02 422.02 0.0
9. Val-Gly-Arg [C13H26N6O4 + 107Ag]+ 437.11 437.11 0.0
10. S-Adenosylmethionine [C15H23N6O5S + K]+ 438.11 438.11 0.0
11. Ala-Cys-Gly-Arg [C14H27N7O5S + K]+ 444.14 444.14 0.0
12. Phe-Trp-Gly [C22H24N4O4 + K]+ 447.14 447.14 0.0
13. Asp-Gly-Arg [C12H22N6O6 + 107Ag]+ 453.07 453.06 22.1
14. Ala-Ala-Ala-Asn [C13H23N5O6 + 109Ag]+ 454.07 454.07 0.0
15. Dopaxanthin [C18H18N2O8 + 107Ag]+ 497.01 497.01 0.0
[C18H18N2O8 + 109Ag]+ 499.01 499.01 0.0
16. CPA(18:2(9Z,12Z)/0:0) [C21H37O6P + 109Ag]+ 525.14 525.14 0.0
17. CPA(18:1(11Z)/0:0) [C21H39O6P + 109Ag]+ 527.15 527.15 0.0
18. Ile-Lys-Tyr [C21H34N4O5 + 107Ag]+ 529.16 529.16 0.0
19 PS(17:2(9Z,12Z)/0:0) [C23H42NO9P + Na]+ 530.25 530.25 0.0
20. PA(17:0/0:0) [C20H41O7P + 107Ag]+ 531.16 531.16 0.0
21. Arg-Ile-Ile-Pro [C23H43N7O5 + K]+ 536.29 536.30 −18.6
22. PG(12:0/0:0) [C18H37O9P + 109Ag]+ 537.12 537.12 0.0
23. LysoPC(18:4(6Z,9Z,12Z,15Z)) [C26H46NO7P + Na]+ 538.29 538.29 0.0
24. Ala-Glu-Ile-Thr [C18H32N4O8 + 107Ag]+ 539.13 539.13 0.0
25. Asn-Leu-Phe-Phe [C28H37N5O6 + H]+ 540.28 540.28 0.0
26. Ala-Phe-Val-Pro [C22H32N4O5 + 109Ag]+ 541.14 541.14 0.0
27. His-Lys-Val-His [C23H37N9O5 + Na]+ 542.28 542.28 0.0
28. Glu-Glu-Met-Pro [C20H32N4O9S + K]+ 543.15 543.15 0.0
29. PC(O-10:1(9E)/2:0) [C20H40NO7P + 107Ag]+ 544.16 544.16 0.0
30. LysoPA(0:0/18:1(9Z)) [C21H41O7P + 109Ag]+ 545.16 545.16 0.0
31. Asn-Trp-Asp-Pro [C24H30N6O8 + Na]+ 553.20 553.20 0.0
32. Lys-Trp-Gly-Gly [C21H30N6O5 + 109Ag]+ 555.13 555.13 0.0
33. Ala-Cys-Tyr-Tyr [C24H30N4O7S + K]+ 557.14 557.15 −17.9
34. Arg-Asn-Asp-Gly [C16H28N8O8 + 107Ag]+ 567.11 567.11 0.0
35. Phe-Thr-Pro-Pro [C23H32N4O6 + 109Ag]+ 569.14 569.14 0.0
36. Thr-Trp-Arg [C21H31N7O5 + 109Ag]+ 570.14 570.14 0.0
37. Ile-Met-Thr-Thr [C19H36N4O7S + 107Ag]+ 571.13 571.14 −17.5
38. Cys-Ser-Tyr-Tyr [C24H30N4O8S + K]+ 573.14 573.14 0.0
39. Phe-Gly-Ser-Tyr [C23H28N4O7 + 109Ag]+ 581.10 581.10 0.0
40. Asn-Leu-Asn-Asp [C18H30N6O9 + 109Ag]+ 583.11 583.11 0.0
41. Ala-Phe-Asn-Gln [C21H30N6O7 + 107Ag]+ 585.12 585.12 0.0
[C21H30N6O7 + 109Ag]+ 587.12 587.12 0.0
42. His-Met-Phe-Gly [C22H30N6O5S + 107Ag]+ 597.10 597.10 0.0
43. Arg-Cys-Gln-Ser [C17H32N8O7S + 107Ag]+ 599.12 599.12 0.0
[C17H32N8O7S + 109Ag]+ 601.12 601.12 0.0
44. Cys-Met-Phe-Thr [C21H32N4O6S2 + 109Ag]+ 609.08 609.08 0.0
45. Asp-Met-Thr-His [C19H30N6O8S + 109Ag]+ 611.09 611.09 0.0
46. Ala-Trp-Cys-Gln [C22H30N6O6S + 107Ag]+ 613.10 613.10 0.0
[C22H30N6O6S + 109Ag]+ 615.10 615.10 0.0
47. Asp-Met-Asp-His [C19H28N6O9S + 107Ag]+ 623.07 623.07 0.0
48. Cys-Met-Thr-Tyr [C21H32N4O7S2 + 109Ag]+ 625.08 625.08 0.0
49. Poly-g-D-glutamate [C20H30N4O12 + 109Ag]+ 627.09 627.09 0.0
50. Asn-Met-Met-Gln [C19H34N6O7S2 + 107Ag]+ 629.10 629.10 0.0
51. P-(bromoacetamido)phenyl uridylpyrophosphate [C17H20BrN3O13P2 + Na]+ 637.96 637.95 15.7
52. Asn-Trp-Asp-Cys [C22H28N6O8S + 107Ag]+ 643.08 643.07 15.6
53. TG(12:0/12:0/20:0) [C47H90O6 + H]+ 751.68 751.68 0.0
54. Stigmast-5,22E-dien-3beta-yl (13Z-docosenoate) [C51H88O2 + Na]+ 755.67 755.67 0.0
[C51H88O2 + K]+ 771.64 771.64 0.0
55. PE(15:0/22:0) [C42H84NO8P + H]+ 762.60 762.60 0.0
56. GlcCer(d18:2/21:0) [C45H85NO8 + H]+ 768.64 768.63 13.0
57. PS(17:1(9Z)/20:4(5Z,8Z,11Z,14Z)) [C43H74NO10P + K]+ 834.47 834.47 0.0
58. PG(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) [C44H77O10P + K]+ 835.48 835.49 −12.0
59. N-(2-hydroxy-eicosanoyl)-1-beta-glucosyl-4E,6E-pentadecasphingadienine [C41H77NO9 + 109Ag]+ 836.47 836.46 12.0
60. PG(20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) [C46H71O10P + Na]+ 837.47 837.47 0.0
61. TG(16:1(9Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)) [C55H92O6 + H]+ 849.70 849.70 0.0
62. [PC (3:0/3:0/3:0)] 1-(2E,6E,10E-phytatrienyl)-2-(2E,6E10E-phytatrienyl)-sn-glycero-3-phosphocholine [C48H88NO6P + 107Ag]+ 912.54 912.54 0.0
63. PG(O-20:0/19:1(9Z)) [C45H89O9P + 109Ag]+ 913.53 913.53 0.0
64. PG(22:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) [C50H85O10P + K]+ 915.56 915.55 10.9
65. PC(22:4(7Z,10Z,13Z,16Z)/P-18:1(11Z)) [C48H86NO7P + 107Ag]+ 926.51 926.52 −10.8
66. PS(17:0/22:1(11Z)) [C45H86NO10P + 109Ag]+ 940.51 940.50 10.6
67. PIP(16:0/18:0) [C43H84O16P2 + Na]+ 941.51 941.51 0.0
68. LacCer(d18:0/14:0) [C44H85NO13 + 107Ag]+ 942.51 942.51 0.0
69. PI(17:2(9Z,12Z)/18:4(6Z,9Z,12Z,15Z)) [C44H73O13P + 107Ag]+ 947.39 947.38 10.6
[C44H73O13P + 109Ag]+ 949.39 949.38 10.5
70. PS(P-20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) [C48H82NO9P + 107Ag]+ 954.49 954.48 10.5
[C48H82NO9P + 109Ag]+ 956.48 956.48 0.0
71. PI(O-16:0/20:2(11Z,14Z)) [C45H85O12P + 107Ag]+ 955.49 955.48 10.5
72. PI(15:0/20:1(11Z)) [C44H83O13P + 107Ag]+ 957.47 957.46 10.4
73. PI(17:1(9Z)/20:3(8Z,11Z,14Z)) [C46H81O13P + 109Ag]+ 981.44 981.45 −10.2
74. TG(19:1(9Z)/21:0/21:0) [C64H122O6 + H]+ 987.94 987.93 10.1
75. 5-formyl-tetrahydrosarcinapterin [C36H52N7O20P + 107Ag]+ 1040.21 1040.21 0.0
76. Lipid IVA [C68H126N2O23P2 + H]+ 1401.84 1401.83 7.1
77. Tetrahexosylceramide (d18:1/26:1(17Z)) [C70H128N2O23 + K]+ 1403.85 1403.85 0.0

* Putative metabolite.